Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

ECFS best practice guidelines: the 2018 revision.

Castellani C, Duff AJA, Bell SC, Heijerman HGM, Munck A, Ratjen F, Sermet-Gaudelus I, Southern KW, Barben J, Flume PA, Hodková P, Kashirskaya N, Kirszenbaum MN, Madge S, Oxley H, Plant B, Schwarzenberg SJ, Smyth AR, Taccetti G, Wagner TOF, Wolfe SP, Drevinek P.

J Cyst Fibros. 2018 Mar;17(2):153-178. doi: 10.1016/j.jcf.2018.02.006. Epub 2018 Mar 3. Review.

2.

Chronic infection sustained by a Pseudomonas aeruginosa High-Risk clone producing the VIM-1 metallo-β-lactamase in a cystic fibrosis patient after lung transplantation.

Pollini S, Mugnaioli C, Dolce D, Campana S, Neri AS, Taccetti G, Rossolini GM.

J Cyst Fibros. 2018 Feb 12. pii: S1569-1993(18)30010-9. doi: 10.1016/j.jcf.2018.01.007. [Epub ahead of print]

PMID:
29444761
3.

A Different Microbiome Gene Repertoire in the Airways of Cystic Fibrosis Patients with Severe Lung Disease.

Bacci G, Mengoni A, Fiscarelli E, Segata N, Taccetti G, Dolce D, Paganin P, Morelli P, Tuccio V, De Alessandri A, Lucidi V, Bevivino A.

Int J Mol Sci. 2017 Jul 29;18(8). pii: E1654. doi: 10.3390/ijms18081654.

4.

Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis.

Stefani S, Campana S, Cariani L, Carnovale V, Colombo C, Lleo MM, Iula VD, Minicucci L, Morelli P, Pizzamiglio G, Taccetti G.

Int J Med Microbiol. 2017 Sep;307(6):353-362. doi: 10.1016/j.ijmm.2017.07.004. Epub 2017 Jul 19. Review.

PMID:
28754426
5.

Mycobacterium abscessus in patients with cystic fibrosis: low impact of inter-human transmission in Italy.

Tortoli E, Kohl TA, Trovato A, Baldan R, Campana S, Cariani L, Colombo C, Costa D, Cristadoro S, Di Serio MC, Manca A, Pizzamiglio G, Rancoita PMV, Rossolini GM, Taccetti G, Teri A, Niemann S, Cirillo DM.

Eur Respir J. 2017 Jul 13;50(1). pii: 1602525. doi: 10.1183/13993003.02525-2016. Print 2017 Jul. No abstract available.

PMID:
28705942
6.

Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacteriumabscessus subsp. bolletii and designation of Mycobacteriumabscessus subsp. massiliense comb. nov.

Tortoli E, Kohl TA, Brown-Elliott BA, Trovato A, Leão SC, Garcia MJ, Vasireddy S, Turenne CY, Griffith DE, Philley JV, Baldan R, Campana S, Cariani L, Colombo C, Taccetti G, Teri A, Niemann S, Wallace RJ Jr, Cirillo DM.

Int J Syst Evol Microbiol. 2016 Nov;66(11):4471-4479. doi: 10.1099/ijsem.0.001376. Epub 2016 Aug 4.

PMID:
27499141
7.

Correction: Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.

Bacci G, Paganin P, Lopez L, Vanni C, Dalmastri C, Cantale C, Daddiego L, Perrotta G, Dolce D, Morelli P, Tuccio V, De Alessandri A, Fiscarelli EV, Taccetti G, Lucidi V, Bevivino A, Mengoni A.

PLoS One. 2016 Aug 1;11(8):e0160726. doi: 10.1371/journal.pone.0160726. eCollection 2016.

8.

Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.

Bacci G, Paganin P, Lopez L, Vanni C, Dalmastri C, Cantale C, Daddiego L, Perrotta G, Dolce D, Morelli P, Tuccio V, De Alessandri A, Fiscarelli EV, Taccetti G, Lucidi V, Bevivino A, Mengoni A.

PLoS One. 2016 Jun 29;11(6):e0156807. doi: 10.1371/journal.pone.0156807. eCollection 2016. Erratum in: PLoS One. 2016;11(8):e0160726.

9.

Within-host microevolution of Pseudomonas aeruginosa in Italian cystic fibrosis patients.

Marvig RL, Dolce D, Sommer LM, Petersen B, Ciofu O, Campana S, Molin S, Taccetti G, Johansen HK.

BMC Microbiol. 2015 Oct 19;15:218. doi: 10.1186/s12866-015-0563-9.

10.

An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis.

Geake JB, Reid DW, Currie BJ, Bell SC; MelioidCF Investigators, Bright-Thomas R, Dewar J, Holden S, Simmonds N, Gyi K, Kenna D, Waters V, Jackson M, O'Sullivan B, Taccetti G, Kolbe J, O'Carroll M, Campbell D, Jaksic M, Radhakrishna N, Kidd TJ, Flight W.

BMC Pulm Med. 2015 Oct 9;15:116. doi: 10.1186/s12890-015-0109-9.

11.

Genomes analysis and bacteria identification: The use of overlapping genes as molecular markers.

Perrin E, Fondi M, Maida I, Mengoni A, Chiellini C, Mocali S, Cocchi P, Campana S, Taccetti G, Vaneechoutte M, Fani R.

J Microbiol Methods. 2015 Oct;117:108-12. doi: 10.1016/j.mimet.2015.07.025. Epub 2015 Jul 30.

PMID:
26235543
12.

Changes in cystic fibrosis airway microbial community associated with a severe decline in lung function.

Paganin P, Fiscarelli EV, Tuccio V, Chiancianesi M, Bacci G, Morelli P, Dolce D, Dalmastri C, De Alessandri A, Lucidi V, Taccetti G, Mengoni A, Bevivino A.

PLoS One. 2015 Apr 21;10(4):e0124348. doi: 10.1371/journal.pone.0124348. eCollection 2015.

13.

Acquired Factor XI Inhibitor Presenting as Spontaneous Bilateral Subdural Hematoma in an Elderly Patient.

Vazzana N, Scarti L, Beltrame C, Picchi A, Taccetti G, Fortini A.

Case Rep Hematol. 2014;2014:626831. doi: 10.1155/2014/626831. Epub 2014 Nov 6.

14.

Early detection of infection with Pseudomonas aeruginosa in cystic fibrosis: the Holy Grail or an achievable goal?

Taccetti G, Sly PD.

J Cyst Fibros. 2014 Sep;13(5):491-3. doi: 10.1016/j.jcf.2014.08.001. Epub 2014 Aug 23. No abstract available.

15.

Management of skin abscesses.

Cocchi P, Taccetti G, Galli L.

N Engl J Med. 2014 Jun 5;370(23):2244-5. doi: 10.1056/NEJMc1404437. No abstract available.

PMID:
24897094
16.

European Cystic Fibrosis Society Standards of Care: Best Practice guidelines.

Smyth AR, Bell SC, Bojcin S, Bryon M, Duff A, Flume P, Kashirskaya N, Munck A, Ratjen F, Schwarzenberg SJ, Sermet-Gaudelus I, Southern KW, Taccetti G, Ullrich G, Wolfe S; European Cystic Fibrosis Society.

J Cyst Fibros. 2014 May;13 Suppl 1:S23-42. doi: 10.1016/j.jcf.2014.03.010. Review.

17.

Bacterial lung infections in cystic fibrosis patients: an update.

Chiappini E, Taccetti G, de Martino M.

Pediatr Infect Dis J. 2014 Jun;33(6):653-4. doi: 10.1097/INF.0000000000000347. Review. No abstract available.

PMID:
24642521
18.

Evaluation of specific immune response in early P. aeruginosa infection in cystic fibrosis patients.

Dolce D, Cariani L, Campana S, Ravenni N, Mergni G, Biffi A, Colombo C, Gagliardini R, Cirilli N, Manso E, Padoan R, Soncini E, Forte FR, D'Aprile A, Ratclif L, Amboni M, Casciaro R, Minicucci L, Borio T, Cosimi A, Vieni G, Zinnarello C, Fiscarelli E, Collura M, Pensabene T, Braggion C, Döring G, Taccetti G.

J Cyst Fibros. 2014 Jan;13(1):116-7. doi: 10.1016/j.jcf.2013.08.003. Epub 2013 Sep 7. No abstract available.

19.

Evidence of transmission of a Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus clone: a family affair.

Cocchi P, Taccetti G, Montagnani C, Campana S, Galli L, Braggion C, de Martino M.

Clin Microbiol Infect. 2013 Dec;19(12):1158-62. doi: 10.1111/1469-0691.12159. Epub 2013 Feb 26. Erratum in: Clin Microbiol Infect. 2014 Jan;20(1):96.

20.

Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols.

Taccetti G, Bianchini E, Cariani L, Buzzetti R, Costantini D, Trevisan F, Zavataro L, Campana S; Italian Group for P aeruginosa Eradication in Cystic Fibrosis.

Thorax. 2012 Oct;67(10):853-9. Epub 2012 Feb 29.

PMID:
22379071
21.

Molecular epidemiology of meticillin-resistant Staphylococcus aureus in Italian cystic fibrosis patients: a national overview.

Cocchi P, Cariani L, Favari F, Lambiase A, Fiscarelli E, Gioffré FV, d'Aprile A, Manso E, Taccetti G, Braggion C, Döring G, de Martino M, Campana S.

J Cyst Fibros. 2011 Dec;10(6):407-11. doi: 10.1016/j.jcf.2011.06.005. Epub 2011 Jul 12.

22.

Influenza A/H1N1 in patients with cystic fibrosis in Italy: a multicentre cohort study.

Colombo C, Battezzati PM, Lucidi V, Magazzù G, Motta V, Alicandro G, Taccetti G, Repetto T.

Thorax. 2011 Mar;66(3):260-1. doi: 10.1136/thx.2010.157032. Epub 2011 Jan 12. No abstract available.

PMID:
21228422
23.

Lactate in cystic fibrosis sputum.

Bensel T, Stotz M, Borneff-Lipp M, Wollschläger B, Wienke A, Taccetti G, Campana S, Meyer KC, Jensen PØ, Lechner U, Ulrich M, Döring G, Worlitzsch D.

J Cyst Fibros. 2011 Jan;10(1):37-44. doi: 10.1016/j.jcf.2010.09.004. Epub 2010 Oct 13.

24.

Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?

Macdonald D, Cuthbertson L, Doherty C, Campana S, Ravenni N, Taccetti G, Govan JR.

J Antimicrob Chemother. 2010 Nov;65(11):2373-5. doi: 10.1093/jac/dkq342. Epub 2010 Sep 13.

PMID:
20837573
25.

Community-associated meticillin-resistant Staphylococcus aureus.

Taccetti G, Cocchi P, Festini F, Braggion C, Campana S.

Lancet. 2010 Sep 4;376(9743):767-8. doi: 10.1016/S0140-6736(10)61371-2. No abstract available.

PMID:
20816537
26.

Case report: cystic fibrosis, lung transplantation, and the novel H1N1 flu.

Bresci S, Borchi B, Ambu S, Taccetti G, Braggion C, Leoncini F.

Transplant Proc. 2010 Jul-Aug;42(6):2270-3. doi: 10.1016/j.transproceed.2010.05.028.

PMID:
20692461
27.

A 1-m distance is not safe for children with cystic fibrosis at risk for cross-infection with Pseudomonas aeruginosa.

Festini F, Taccetti G, Galici V, Neri S, Bisogni S, Ciofi D, Braggion C.

Am J Infect Control. 2010 Apr;38(3):244-5. doi: 10.1016/j.ajic.2009.09.017. Epub 2010 Feb 2.

PMID:
20129701
28.

Application of multiplex single nucleotide primer extension (mSNuPE) to the identification of bacteria: the Burkholderia cepacia complex case.

Ferri L, Perrin E, Campana S, Tabacchioni S, Taccetti G, Cocchi P, Ravenni N, Dalmastri C, Chiarini L, Bevivino A, Manno G, Mentasti M, Fani R.

J Microbiol Methods. 2010 Mar;80(3):251-6. doi: 10.1016/j.mimet.2010.01.008. Epub 2010 Jan 14.

PMID:
20079386
29.

The costs of treatment of early and chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.

Braccini G, Festini F, Boni V, Neri AS, Galici V, Campana S, Zavataro L, Trevisan F, Braggion C, Taccetti G.

J Chemother. 2009 Apr;21(2):188-92.

PMID:
19423472
30.

Parenteral administration of tobramycin for pulmonary exacerbations in cystic fibrosis patients: toxicity, serum levels and efficacy.

Braccini G, Lori I, Neri AS, Festini F, Pela I, Ciuti R, Boni V, Zavataro L, Braggion C, De Martino M, Taccetti G.

J Chemother. 2009 Feb;21(1):101-4. No abstract available.

PMID:
19297282
31.

Incidence of cystic fibrosis in the Albanian population.

Festini F, Taccetti G, Repetto T, Mannini C, Neri S, Bisogni S, de Martino M.

Pediatr Pulmonol. 2008 Nov;43(11):1124-1129. doi: 10.1002/ppul.20920.

PMID:
18972414
32.

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis.

Taccetti G, Campana S, Neri AS, Boni V, Festini F.

J Chemother. 2008 Apr;20(2):166-9. Review.

PMID:
18467240
33.

Bone mineral density in cystic fibrosis patients under the age of 18 years.

Neri AS, Lori I, Festini F, Masi L, Brandi ML, Galici V, Braggion C, Taccetti G.

Minerva Pediatr. 2008 Apr;60(2):147-54.

PMID:
18449130
34.

Long-term health outcomes of neonatal screening for cystic fibrosis.

Festini F, Taccetti G, Galici V, Campana S, Mergni G, Repetto T.

Arch Dis Child. 2008 Apr;93(4):357-8. doi: 10.1136/adc.2008.137067. No abstract available.

PMID:
18356397
35.

Use of the gyrB gene to discriminate among species of the Burkholderia cepacia complex.

Tabacchioni S, Ferri L, Manno G, Mentasti M, Cocchi P, Campana S, Ravenni N, Taccetti G, Dalmastri C, Chiarini L, Bevivino A, Fani R.

FEMS Microbiol Lett. 2008 Apr;281(2):175-82. doi: 10.1111/j.1574-6968.2008.01105.x. Epub 2008 Feb 27.

36.

Methicillin resistant Staphylococcus aureus in cystic fibrosis.

Taccetti G, Neri AS, Festini F, Galici V, Cocchi P, Campana S.

Pediatr Pulmonol. 2008 Mar;43(3):309; author reply 310. doi: 10.1002/ppul.20774. No abstract available.

PMID:
18214947
37.

Emergence of an epidemic clone of community-associated methicillin-resistant panton-valentine leucocidin-negative Staphylococcus aureus in cystic fibrosis patient populations.

Campana S, Cocchi P, Döring G, Taccetti G, Moroney SM.

J Clin Microbiol. 2007 Sep;45(9):3146; author reply 3146-7. No abstract available.

38.

Patient risk of contact with respiratory pathogens from inanimate surfaces in a cystic fibrosis outpatient clinic. A prospective study over a four-year period.

Festini F, Taccetti G, Mannini C, Campana S, Mergni G, Vignoli N, Allegretti N, Ravenni N, Cocchi P, Neri S, Repetto T, de Martino M.

Pediatr Pulmonol. 2007 Sep;42(9):779-84.

PMID:
17639586
39.

Alteration of bone mineral density in cystic fibrosis adults.

Neri AS, Lori I, Taccetti G, Festini F, de Martino M, Masi L, Brandi ML.

Chest. 2006 Dec;130(6):1952-3; author reply 1953. No abstract available.

PMID:
17167027
40.

Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex.

Herasimenka Y, Cescutti P, Impallomeni G, Campana S, Taccetti G, Ravenni N, Zanetti F, Rizzo R.

J Cyst Fibros. 2007 Apr;6(2):145-52. Epub 2006 Jul 21.

41.

Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review.

Festini F, Buzzetti R, Bassi C, Braggion C, Salvatore D, Taccetti G, Mastella G.

J Hosp Infect. 2006 Sep;64(1):1-6. Epub 2006 Jul 10. Review.

PMID:
16835001
42.

Breast-feeding in a woman with cystic fibrosis undergoing antibiotic intravenous treatment.

Festini F, Ciuti R, Taccetti G, Repetto T, Campana S, De Martino M.

J Matern Fetal Neonatal Med. 2006 Jun;19(6):375-6.

PMID:
16801316
43.

[Bronchiectasis worsening by p-ANCA (bactericidal/permeability-increasing protein) positive vasculitis. A case report and review of the literature].

Benucci M, Nenci G, Taccetti G, Rosso A, Beltrame C, Cappelletti C, Manfredi M.

Ann Ital Med Int. 2005 Oct-Dec;20(4):258-61. Review. Italian.

PMID:
16610259
44.

Eradication of Pseudomonas aeruginosa in cystic fibrosis patients.

Döring G, Taccetti G, Campana S, Festini F, Mascherini M.

Eur Respir J. 2006 Mar;27(3):653. No abstract available.

45.

National scientific associations should have a key role in adapting and implementing standard of care guidelines in European countries.

Braggion C, Alatri F, Conese M, Festini F, Gagliardini R, Raia V, Seia M, Taccetti G; Executive Committee of the Italian Cystic Fibrosis Society.

J Cyst Fibros. 2005 Dec;4(4):271-2. Epub 2005 Oct 25. No abstract available.

46.

Use of continuous subcutaneous insulin infusion in cystic fibrosis patients with cystic fibrosis-related diabetes awaiting transplantation.

Reali MF, Festini F, Neri AS, Taccetti G, Repetto T, Chiarelli F, Toni S.

J Cyst Fibros. 2006 Jan;5(1):67-8. Epub 2005 Oct 17. No abstract available.

47.

Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy.

Campana S, Taccetti G, Ravenni N, Favari F, Cariani L, Sciacca A, Savoia D, Collura A, Fiscarelli E, De Intinis G, Busetti M, Cipolloni A, d'Aprile A, Provenzano E, Collebrusco I, Frontini P, Stassi G, Trancassini M, Tovagliari D, Lavitola A, Doherty CJ, Coenye T, Govan JR, Vandamme P.

J Clin Microbiol. 2005 Oct;43(10):5136-42.

48.

Gestational and neonatal characteristics of children with cystic fibrosis: a cohort study.

Festini F, Taccetti G, Repetto T, Reali MF, Campana S, Mergni G, Marianelli L, de Martino M.

J Pediatr. 2005 Sep;147(3):316-20.

PMID:
16182668
49.

Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.

Taccetti G, Campana S, Festini F, Mascherini M, Döring G.

Eur Respir J. 2005 Sep;26(3):458-61.

50.

Clinical follow-up of 122 Italian cystic fibrosis patients with B. cepacia complex colonisation.

Taccetti G, Costantini D, Furnari ML.

J Cyst Fibros. 2005 May;4(2):145-6; author reply 147. Epub 2005 Feb 16. No abstract available.

Supplemental Content

Loading ...
Support Center